Essential Pharma
Gursharan Randhawa has a wealth of experience in the field of Mergers & Acquisitions, Corporate and Business Development, Business Intelligence, and Technology Transfer. In 2021, they joined Essential Pharma as Senior Director of Mergers & Acquisitions and Director of Mergers & Acquisitions. From 2018 to 2021, they were employed at Theramex as Director of Corporate and Business Development and Associate Director of Business Development. From 2017 to 2018, they worked at Mundipharma International Limited as Business Intelligence Lead of Corporate & Business Development and Commercial Analytics. From 2013 to 2017, they were a volunteer at Venture Partnership Foundation, conducting Due Diligence for Social Enterprises and Charities. From 2009 to 2013, they were employed at Imperial Innovations as Senior Healthcare Licensing Executive, Technology Transfer Executive, and Technology Transfer Associate. Additionally, they were Technology Transfer at Queen Mary Innovation from 2009 to 2013.
Gursharan Randhawa completed a BSc in Biochemistry from Imperial College London from 2004 to 2007. Following this, they completed an MSc in Science Communication from Imperial College London from 2007 to 2008.
This person is not in any offices
Essential Pharma
Essential Pharma ensures the sustainable supply of low volume, difficult to manufacture but clinically well-established pharmaceutical products to patients. These branded and generic medicines form an essential part of the pharmacopeia and represent many therapeutic areas. The company is an important partner to healthcare providers by providing medicines that otherwise would not be available.